ONEPASS NUCLEAR IMAGING SYSTEM, MODEL 70-500101

• K Number: K023373
• Device Name: ONEPASS NUCLEAR IMAGING SYSTEM, MODEL 70-500101
• Manufacturer: GVI TECHNOLOGY PARTNERS
• Date Cleared: 2003-01-03 ( 87 days)
• Product Code: IYX , CLA
• Regulation Number: 892.1100
• Type: Traditional
• Panel: Radiology
• Reference & Predicate Devices: K931193
• Predicate For: K051402 , K072191

Intended Use

The OnePass nuclear medicine imaging system is intended for use as a diagnostic imaging device. Used with appropriate radiopharmaceuticals, it produces images that depict the anatomical distribution of radioisotopes within the human body. The OnePass system's compact footprint and small FOV detector are specifically designed for placement in a facility lacking adequate floor space for a typical nuclear medicine imaging system.

The OnePass system's design is optimized for acquiring and processing cardiac first pass data. First-pass radionuclide angiography (FPRNA) is used to assess left and right ventricular function at rest or during stress.

Device Description

The OnePass Nuclear Medicine Imaging Systems acquires and processes gated First Pass Radionuclide Angiography (FPRNA) images. After completion of acquisition, both qualitative and quantitative results are available to the physician for analysis.

The acquisition system consists of a single small field-of-view detector mounted on an articulating arm to allow precise positioning of the detector over the patient's heart. In addition, a vertical lift adjusts the detector height position to track changes in the incline of the treadmill to ensure camera remains positioned directly over the patient's heart during acquisition.

AI/ML Overview

The provided text is a 510(k) summary for the OnePass Nuclear Medicine Imaging System. It describes the device, its intended use, and claims substantial equivalence to a predicate device. However, it does not contain information about acceptance criteria, a study proving the device meets acceptance criteria, reported device performance metrics, sample sizes, ground truth establishment methods, or any details about human reader studies (MRMC or standalone).

The document primarily focuses on:

• Device identification: Name, classification, contact information.
• Device description: How it acquires and processes gated First Pass Radionuclide Angiography (FPRNA) images using a single small field-of-view detector.
• Intended Use: Diagnostic imaging to depict anatomical distribution of radioisotopes, specifically optimized for cardiac first pass data to assess left and right ventricular function.
• Predicate Device: Scinticor SIM-400 System (K931193).
• Claim of Substantial Equivalence: The OnePass is comparable and substantially equivalent to the SIM-400 for FPRNA studies, with the primary difference being that OnePass is optimized only for FPRNA, while SIM-400 can perform other study types.
• Conclusion: No new safety risks, performs as well as the SIM-400 for FPRNA.
• FDA Clearance Letter: A formal letter from the FDA granting clearance based on the substantial equivalence claim.

Therefore, I cannot fulfill your request for the specific details regarding acceptance criteria, study design, and performance metrics as they are not present in the provided text. The document is a regulatory submission, not a detailed scientific study report.

Summary

{0}------------------------------------------------

510(k) Summary of Safety and Effectiveness D

Image /page/0/Picture/3 description: The image shows the logo for "GI Medical Devices". The logo consists of a stylized "GI" in a bold, black font. To the right of the "GI" is the text "MEDICAL DEVICES", also in a bold, black font. The logo is simple and professional, and it is likely used to represent a company that manufactures or distributes medical devices.

Date Prepared

Contact:

Fax:

E-mail:

Telephone:

Registration Number:

Device Name and Classification

CDRH Product Code:

Classification Panel:

Proprietary Name:

Regulatory Device Class:

21 CFR Number:

1-October-2002

Establishment Name and Registration Number

Manufacturer Name and Address:

GVI Medical Devices 1470 Enterprise Parkway Twinsburg, Ohio 44087 Kevin Murrock 330-963-4083 330-963-4084 mailto:[e-mail] None 892.1100 90 IYX -Radiology OnePass Nuclear Imaging System Gamma Camera System Camera, Scintillation (Gamma)

Common Name: Classification Name:

Reason for 510(k) Submission

New Device

Predicate Device

SIM-400 System, Scinticor, Inc. 510(k) Number: K931193

Device Description

The OnePass Nuclear Medicine Imaging Systems acquires and processes gated First Pass Radionuclide Angiography (FPRNA) images. After completion of acquisition, both qualitative and quantitative results are available to the physician for analysis.

The acquisition system consists of a single small field-of-view detector mounted on an articulating arm to allow precise positioning of the detector over the patient's heart. In addition, a vertical lift adjusts the detector height position to track changes in the incline of the treadmill to ensure camera remains positioned directly over the patient's heart during acquisition.

K623373

1470 Enterprise Parkway Twinsburg, Ohio 44087 Phone: [phone] Fax: [phone]

JAN 0 3 2003

{1}------------------------------------------------

Intended Use

The OnePass nuclear medicine imaging system is intended for use as a diagnostic imaging device. Used with appropriate radiopharmaceuticals, it produces images that depict the anatomical distribution of radioisotopes within the human body. The OnePass system's compact footprint and small FOV detector are specifically designed for placement in a facility lacking adequate floor space for a typical nuclear medicine imaging system.

The OnePass system's design is optimized for acquiring and processing cardiac first pass data. First-pass radionuclide angiography (FPRNA) is used to assess left and right ventricular function at rest or during stress.

Substantial Equivalence

The OnePass is of a comparable type and substantially equivalent to the Scinticor SIM-400 System (510(k) Number K931193). Both devices are used to perform First-Pass Radionuclide Angiography (FPRNA) studies and contain similar performance characteristics. The primary difference between the devices is that the OnePass is optimized for performing only FPRNA studies, while the SIM-400 is capable of performing additional study types such as cardiac SPECT.

Conclusion

The OnePass does not result in any new potential safety risks and performs as well as the SIM-400 for performing FPRNA studies.

{2}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service

00 Corporate Boulevard ockville MD. 20850

JAN 03 2003

Mr. Kevin M. Murrock GVI Medical Devices 1470 Enterprise Parkway TWINSBURG OH 44087 Re: K023373

Trade/Device Name: OnePass Nuclear Medicine Imaging System Regulation Number: 21 CFR 892:1100 Regulation Name: Scintillation (gamma) camera Regulatory Class: I Product Code: 90 IYX Dated: October 1, 2002 Received: October 8, 2002

Dear Mr. Murrock:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.

{3}------------------------------------------------

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed . predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:

8xx.1xxx	[phone]
876.2xxx, 3xxx, 4xxx, 5xxx	[phone]
884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx	[phone]
892.2xxx, 3xxx, 4xxx, 5xxx	[phone]
Other	[phone]

Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.

Sincerely yours,

Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

OnePass Nuclear Medicine Imaging System Section C. Indications for Use Statement

Indications for Use Statement C

510(k) Number (if known):

Device Name: OnePass Nuclear Medicine Imaging System

Indications for Use: The OnePass nuclear medicine imaging system is intended for use as a diagnostic imaging device. Used with appropriate radiopharmaceuticals, it produces images that depict the : anatomical distribution of radioisotopes within the human body. The OnePass system's compact footprint and small FOV detector are specifically designed for placement in a facility lacking adequate floor space for a typical nuclear medicine imaging system.

The OnePass system's design is optimized for acquiring and processing cardiac first pass data. First-pass radionuclide angiography (FPRNA) is used to assess left and right ventricular function at rest or during stress.

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801-109)

OR

Over-The-Counter Use

510(k) Notificatio

Nancy C. Brogdon

(Division Sign-Off) Division of Fi-productive, Abdominal, and Radiological Devices 5 1 (k) Number

Regulation Number and Section

§ 892.1100 Scintillation (gamma) camera.

(a)
Identification. A scintillation (gamma) camera is a device intended to image the distribution of radionuclides in the body by means of a photon radiation detector. This generic type of device may include signal analysis and display equipment, patient and equipment supports, radionuclide anatomical markers, component parts, and accessories.(b)
Classification. Class I (general controls).